Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Nov 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Four major impacts of artificial intelligence on healthcare

Dec 30
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts predict massive growth in health tech

Jan 11
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pfizer and PostEra collab in $250M AI lab deal

Sep 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Tough Tech Landscape

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Microsoft’s next moves: Biz dev and strategy leader Christopher Young is focusing on these key areas

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Emmanuel Macron unveils a €30 billion plan to create France's 'high tech champions of the future'

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Jan 26
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Globalization and Democratization of Innovation

Dec 28
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Industry insiders recount top medtech wins of 2021

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie